CAACB Events

Events

July 23-24, 2014 The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on The Role of Testing in Control of Viral Contamination in Biopharmaceutical Manufacturing at the MIT Media Lab.
June 9-11, 2014 Dr. Michael Wiebe, Lead Investigator of the CAACB and Dr. Paul Barone, Associate Director of the CAACB co-presented An Update on the Activities of the Consortium on Adventitious Agent Contamination in Biomanufacturing and An Update on the CAACB Virus Contamination Project at the PDA/FDA Virus and TSE Safety Conference in Bethesda.
Dec 9-10, 2013 The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Adventitious Agent Control in Non-Sterile Cell Culture Operations at the MIT Media Lab (Dec 9) and the Boston Marriott Cambridge (Dec 10).
June 24-25, 2013 The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Virus Risk Assessment Approaches at the MIT Faculty Club (June 24) and the Boston Marriott Cambridge (June 25).
July 11, 2013 CAACB and the Biomanufacturing Research Program presented at the Annual Bio-Manufacturing & Process Innovation Leaders Summit in Boston. Dr. Stacy L. Springs, Executive Director of the CAACB and Biomanufacturing Research Program (BioMAN) presented Leveraging Collaborative Innovation: The BioMAN Research Program and Consortium on Adventitious Agent Contamination in Biomanufacturing.
June 4-6, 2013 CAACB Initiative presented at the PDA European Virus & TSE Safety Forum in Berlin. Dr. Michael Wiebe, Lead Investigator of the CAACB presented The MIT / Industry Initiative on Preventing Adventitious Agent Contamination in Biomanufacturing. Read Abstract
April 17, 2013 Dr. James C. Leung, Lead Investigator of the CAACB, presented An Academic and Industry Collaborative Initiative on Preventing Adventitious Agent Contaminations in Biomanufacturing at the Center for Biomedical Innovation’s Seminar Series at MIT.
March 15, 2013 Dr. James C. Leung, Lead Investigator of the CAACB, presented An Academic and Industry Collaborative Initiative on Preventing Adventitious Agent Contaminations in Biomanufacturing at the IS Biotech 3rd Annual Meeting in Rosslyn, VA.
Feb 26, 2013 Dr. Michael Wiebe, Lead Investigator of the CAACB, presented The MIT / Industry Initiative on Preventing Adventitious Agent Contamination in Biomanufacturing during the Viral Safety for Biologics session at the IBC Biopharmaceutical Development and Production week in Huntington Beach, CA.
Dec 13, 2012 The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Virus Contamination at the MIT Faculty Club on December 13th. The workshop consisted of open discussions centered around the viral contamination data collected from our Consortium members. The event brought together more than 40 people from 15 different companies and organizations.
June 21-22, 2012 The MIT CBI’s Consortium on Adventitious Agent Contamination in Biomanufacturing hosted a workshop on Media Treatment in Biomanufacturing at the MIT Faculty Club on June 21st and 22nd. The workshop consisted of 1.5 days of talks, open discussion and networking centered around High Temperature Short Time treatment of cell culture media to inactivate adventitious agents as well as several alternative methods, such as UV-C treatment. The event brought together more than 50 people from 19 different companies and organizations.
June 28-30, 2011 Dr. Houman Dehghani, of Amgen, presented “Maximize the Knowledge of Past Virus Contamination Events to Benefit the Future – An MIT-led and Industry-Sponsored Project” about the CAACB initiative at the PDA’s Virus and TSE Safety Forum in Barcelona.
Dec 1, 2010 Dr. Michael Wiebe presented Industry Consortium on Adventitious Agent Contamination in Biomanufacturing at the PDA/FDA workshop on Adventitious Viruses in Biologics: Detection and Mitigation Strategies
Nov 17, 2010 CAACB Initiative presented at 2010 BioMAN Summit Science to Manage Risk in Biomanufacturing
Nov 17, 2010 Consortium on Adventitious Agent Contamination in Biomanufacturing Kick-off Meeting

Archive

The CBI’s Consortium on Adventitious Agent Contamination in Biopharmaceutical Manufacturing featured in Nature editorial. (April 28, 2011)
A recent Nature editorial discusses the problem of viral contamination in biopharmaceutical manufacturing. The editorial highlights the work being done at MIT, through the CAACB, and the potential positive impact on the biopharmaceutical industry. Read More.
MIT CBI launches new biopharmaceutical manufacturing industry initiative to tackle adventitious agent contamination. (January 1, 2011)
The MIT Center for Biomedical Innovation has launched a new industrial initiative, the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), beginning to address an industry-wide problem. With vital industry participation, the CAACB will collect, analyze and share industry risks and prevention strategies regarding adventitious agent contamination.